THE EPO 'results' are being debunked already, but the EPO's PR team keeps spreading that today, regardless of all the scrutiny [1, 2]. How much longer is this sustainable for?
"How much longer is this sustainable for?"Why is the EPO risking damage to its integrity and record on truth? Well, it already lies to journalists and to staff, so there's probably not much reputation left to lose.
The other day we noticed EPO-friendly media citing the USPTO's Senior Counsel as follows:
USPTO Senior Counsel Mark Cohen notes that aggressive antitrust enforcement like that sought in the Hitachi Metals case could affect patenting activity in general, adding: “This can be of great concern in the non-SEP space, where a patentee may have a choice whether to disclose an invention or keep a proprietary method secret.”
The revised guidelines on computer-related inventions by the Indian Patent Office imply a reversed position on whether software inventions should be patentable. Abhishek Pandurangi of Khurana & Khurana reports.
After the Indian Patent Office (IPO) published the first set of guidelines for examining patents for computer-related inventions in August, in February the office introduced an amended set of rules.
While the previous guidelines were kept in abeyance in response to strong protests by critics, a revision was expected, but surprisingly the IPO has replaced an excessively liberal set of guidelines indicating that any software is patentable with a contrary one which almost indicates that no software patents are allowed.
"The answers to the questions about patent leniency may actually be found in anonymous comments from insiders."Simply put, under Battistelli there is a huge patent maximalism problem. Patent scope gets broadened in pursuit of additional profits, rendering any performance requirement invalid (comparing apples to oranges, if not actually patenting apples and oranges, which now seems possible at the EPO). Yesterday we saw this announcement titled "EPO Revokes a Patent of Biogen, Inc.’s (NASDAQ:BIIB) Top-Selling Tecfidera". Why was this patent granted in the first place? Working under pressure or in rush? Inclination to lower the patent bar and issue/grant bogus patents? Whatever it is, as the article put it: "The European Patent Office (EPO) has revoked European Patent EP2137537, a method of use patent concerning Tecfidera, last week. If left unresolved, the move will take a big hit on Biogen’s balance sheets because sales of Tecfidera account for a third of its overall revenue in 2015."
The answers to the questions about patent leniency may actually be found in anonymous comments from insiders. While many comments on the debunking of EPO 'results' have come from EPO apologists (if not worse) who are simply shooting the messenger, some of them come from insiders who acknowledge the problem (we have been hearing about these problems for a while). To quote:
I accept that life always involves compromises. But it is distressing to see EPO examiners slowly turning into the three wise monkeys (that is, if you don't look too hard for problematic prior art, and don't think too hard about strict compliance with all of the provisions of the EPC, then examination becomes a lot simpler... and faster).
I fully understand what is driving this process, as applicants, the EPO and national patent offices all stand to benefit. However, it does look like it could be the beginning of a process of erosion of the fundamental bargain with the public that underpins the whole patent system.
I am not saying that where we stand now is definitely unacceptable. Instead, I am merely pointing out that what appears to be a drive from the EPO for “examination light” represents a potentially dangerous trend that needs counterbalancing with strong input from voices representing the public interest.
I say this not as a "patent denier" but rather someone who believes in the patent system, and who wants to cherish it for many years to come.
Think about it. If the pendulum swings too far in terms of permissiveness, then there are certain to be cases where aggressive patent owners assert blatantly invalid patents against competitors with shallow pockets – potentially aided by the €11k fee at the UPC for filing a counterclaim for invalidity. It will not take many cases where a patent owner can be painted as a bad actor for there to be overreactions in the opposite direction. If you have any doubts about what can happen, then witness the effect that lobbying by anti-patent pressure groups has had on “gene” (or other “natural phenomenon”) patents in the US and Australia. Scary stuff!
I agree that some of the professed aims of the ECFS system are laudable. Indeed, there is no point prioritising cases where everyone is happy to let sleeping dogs lie. However, it is not hard to see that much of what is prioritised by ECFS are the “easy wins”, where examination is very straightforward.
The inevitable short term hike in productivity figures produced by ECFS is not to be welcomed for two reasons. Firstly, it will leave a rump of “clearly difficult” cases that no examiner wants to tackle – because the time taken to sort them out will be too detrimental to the examiner’s apparent productivity. Secondly, it is likely to provide a strong temptation to examiners to keep their productivity figures high by waiving through “borderline” cases – ie. treating them as if they are also “easy wins”.
Nobody expects the EPO’s search and examination to be exhaustive. However, they will be doing us all a favour if a way is found to reward examiners for doing their job properly – and not just speedily. In this respect, it is important to acknowledge that it is impossible to constantly drive down the time taken to search and examine applications without compromising on quality. The best that you can hope for is an acceptable balance between speed and quality. Thus, management initiatives that seek to constantly increase productivity look increasingly like a drive to reach the bottom of the barrel.
Based on our own experience and talking to others in the profession, it seems that for some examiners getting examination reports issued quickly involves being totally unhelpful, simply not dealing with issues or throwing in a load of amendments and gambling on the applicant just accepting what is given to avoid remaining in examination.
I have recently seen a first examination report to issue on amendments filed in 2011 in response to the EESR. Unfortunately, an amendment shown on a manuscript amended copy of the claims filed with the response did not make it into the clean copy of the claims. The amendment was described at length in the covering letter and is shown clearly on the manuscript amended copy. Rather than examine the claims as including that amendment or call the representative to ask him to submit a clean copy of the claims that included the amendment, some four plus years after the filing of the response, the examiner examined the claims as those the amendment did not exist. Furthermore, despite the fact the representative's letter explained various reasons why other features of claim 1 distinguished over the cited prior art, the examiner has just parroted the objections from the EESR without giving any clue as to why he/she disagrees with the representative's analysis. So about as helpful as a chocolate teapot. However, somewhat craftily, an allowable dependent claim has been allowed.
In a case of my own, we submitted amended claims on entering the regional phase accompanied by a two-part letter explaining the basis for the amendments. Ahead of the search report we got a note from the examiner saying that no basis for the amendments had been supplied when the amendments were filed and if this was not supplied within a month or two, I don't remember which now, the amended claims would not be searched. We were given no more information than that so wrote back pointing out that we had filed a two page letter explaining the basis for the amendments. The response from the examiner was to issue a partial search report with the comment that neither our first letter or our second letter explained the basis for amendments. As far as I can make out, since the **** has not been sufficiently helpful to provide any useful indication, he just did not consider the explanation of the amendments to a couple of claims sufficiently complete. Leaving aside whether he is entitled to ask for further detail at that stage, we might have been able to move things forward if he'd just said asked us to provide additional explanation of the amendments made to particular claims instead of sending out a communication which was misleading and, basically, factually incorrect.
These are just two examples I am aware of and I am guessing that neither I nor those I know in the profession are being singled out for special treatment.
Basically we are seeing cases that already suffer from long delays in examination making no meaningful progress because examiners are simply bloody-minded, unhelpful or do not take the trouble to explain the issue. How much this is down to the mindset of individual examiners and how much a response to management pressure, I really do not know; whatever , it is not doing the reputation of the EPO any favours.